221 related articles for article (PubMed ID: 12752889)
1. Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment.
Walker JG; Ahern MJ; Smith MD; Coleman M; Pile K; Rischmueller M; Cleland L; Roberts-Thomson PJ
Intern Med J; 2003; 33(5-6):216-20. PubMed ID: 12752889
[TBL] [Abstract][Full Text] [Related]
2. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.
Hudson M; Baron M; Tatibouet S; Furst DE; Khanna D;
Semin Arthritis Rheum; 2014 Apr; 43(5):666-72. PubMed ID: 24176729
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma renal crisis.
Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
[TBL] [Abstract][Full Text] [Related]
4. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.
Steen VD; Costantino JP; Shapiro AP; Medsger TA
Ann Intern Med; 1990 Sep; 113(5):352-7. PubMed ID: 2382917
[TBL] [Abstract][Full Text] [Related]
5. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of scleroderma renal crisis.
Steen VD; Medsger TA
Ann Intern Med; 2000 Oct; 133(8):600-3. PubMed ID: 11033587
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognosis of patients with scleroderma renal crisis].
Roda-Safont A; Simeón-Aznar CP; Fonollosa-Plà V; Segarra-Medrano A; Vilardell-Tarrés M
Med Clin (Barc); 2011 Oct; 137(10):431-4. PubMed ID: 21596402
[TBL] [Abstract][Full Text] [Related]
8. Scleroderma renal crisis: observations from the South Australian Scleroderma Register.
Khadra Y; Walker JG; Hakendorf P; Proudman S; Rischmueller M; Hill CL; Whittle S; Pontifex E; Roberts-Thomson PJ
Intern Med J; 2021 Feb; 51(2):235-242. PubMed ID: 32043674
[TBL] [Abstract][Full Text] [Related]
9. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
[TBL] [Abstract][Full Text] [Related]
10. Scleroderma renal crisis: patient characteristics and long-term outcomes.
Penn H; Howie AJ; Kingdon EJ; Bunn CC; Stratton RJ; Black CM; Burns A; Denton CP
QJM; 2007 Aug; 100(8):485-94. PubMed ID: 17601770
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of scleroderma renal crisis: a long-term observational study.
Cozzi F; Marson P; Cardarelli S; Favaro M; Tison T; Tonello M; Pigatto E; De Silvestro G; Punzi L; Doria A
Nephrol Dial Transplant; 2012 Dec; 27(12):4398-403. PubMed ID: 22859795
[TBL] [Abstract][Full Text] [Related]
12. Scleroderma renal crisis.
Bose N; Chiesa-Vottero A; Chatterjee S
Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma renal crisis and renal involvement in systemic sclerosis.
Woodworth TG; Suliman YA; Li W; Furst DE; Clements P
Nat Rev Nephrol; 2016 Nov; 12(11):678-691. PubMed ID: 27641135
[TBL] [Abstract][Full Text] [Related]
14. Renal Involvement in Systemic Sclerosis: An Update.
Chrabaszcz M; Małyszko J; Sikora M; Alda-Malicka R; Stochmal A; Matuszkiewicz-Rowinska J; Rudnicka L
Kidney Blood Press Res; 2020; 45(4):532-548. PubMed ID: 32521536
[TBL] [Abstract][Full Text] [Related]
15. Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literature.
Logee KM; Lakshminarayanan S
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S171-4. PubMed ID: 25797912
[TBL] [Abstract][Full Text] [Related]
16. The scleroderma kidney: progress in risk factors, therapy, and prevention.
Bussone G; Bérezné A; Pestre V; Guillevin L; Mouthon L
Curr Rheumatol Rep; 2011 Feb; 13(1):37-43. PubMed ID: 21061100
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma renal crisis, still a life-threatening complication.
Teixeira L; Mahr A; Berezné A; Noël LH; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1108():249-58. PubMed ID: 17893990
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and long-term outcomes of Chinese patients with scleroderma renal crisis.
Zhou J; Hou Y; Wang Q; Li M; Zeng X; Xu D
Int J Rheum Dis; 2020 Aug; 23(9):1194-1200. PubMed ID: 32700455
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
Bütikofer L; Varisco PA; Distler O; Kowal-Bielecka O; Allanore Y; Riemekasten G; Villiger PM; Adler S;
Arthritis Res Ther; 2020 Mar; 22(1):59. PubMed ID: 32209135
[TBL] [Abstract][Full Text] [Related]
20. Management of scleroderma renal crisis.
Nagaraja V
Curr Opin Rheumatol; 2019 May; 31(3):223-230. PubMed ID: 30870219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
